NT-219: First-In-Class, Novel Small Molecule Designed To ...

NT-219: First-In-Class, Novel Small Molecule Designed To Overcome Cancer Drug Resistance
3 years 478 Views
Category:
Description:
Isaac Israel CEO @isaac2199 Of Kitov Pharmaceuticals Discusses NT-219: First-In-Class, Novel Small Molecule Designed To Overcome Cancer Drug Resistance.